Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis

M Peigné, V Bernard, L Dijols, H Creux… - Human …, 2023 - academic.oup.com
STUDY QUESTION Is serum anti-Müllerian hormone (AMH) level predictive of cumulative
live birth (CLB) rate after ART or in women trying to conceive naturally? SUMMARY …

Is diminished ovarian reserve a risk factor for miscarriage? Results of a systematic review and meta-analysis

A Busnelli, E Somigliana, F Cirillo… - Human Reproduction …, 2021 - academic.oup.com
BACKGROUND Anti-Müllerian hormone (AMH) serum concentration and antral follicle count
(AFC), as measured by transvaginal ultrasonography, accurately reflect the antral follicle …

Anti–müllerian hormone as a predictor for live birth among women undergoing IVF/ICSI in different age groups: an update of systematic review and meta-analysis

NJ Li, QY Yao, X Yuan, Y Huang, YF Li - Archives of Gynecology and …, 2023 - Springer
Purpose To update the evidence of anti–müllerian hormone (AMH) as predictive factors for
live birth outcome in women undergoing assisted conception and discover the modulating …

[HTML][HTML] High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with …

N Su, J Zhan, M Xie, Y Zhao, C Huang… - Frontiers in …, 2023 - frontiersin.org
Objective Anti-Mullerian hormone (AMH) has been recently identified as a potential predictor
of live birth rates (LBRs) following assisted reproductive technology (ART) treatment. This …

[HTML][HTML] In Vitro Fertilisation and Intracytoplasmic Sperm Injection predictive factors: A review of the effect of female age, ovarian reserve, male age, and male factor on …

S Ribeiro, M Sousa - JBRA Assisted Reproduction, 2023 - ncbi.nlm.nih.gov
The development of assisted reproductive technology has allowed offspring in infertile
couples, and specifically, allowed infertile men to conceive through Intracytoplasmic Sperm …

Anti-Mullerian hormone (AMH) test information on Australian and New Zealand fertility clinic websites: a content analysis

T Copp, B Nickel, S Lensen, K Hammarberg… - BMJ open, 2021 - bmjopen.bmj.com
Objectives The anti-Mullerian hormone (AMH) test has been promoted as a way to inform
women about their future fertility. However, data consistently show the test is a poor predictor …

[HTML][HTML] Immunoreactivity of plasminogen activator inhibitor 1 and its correlation with dysmenorrhea and lesional fibrosis in adenomyosis

B Yang, N Gu, S Shi, C Zhang, L Chen, J Ouyang… - Reproductive …, 2021 - Springer
Adenomyosis is associated with dysmenorrhea, infertility, and lesional fibrosis. The
pathogenesis of adenomyosis is still unclear. Plasminogen activator inhibitor 1 (PAI-1) plays …

[HTML][HTML] Adaptive data-driven models to best predict the likelihood of live birth as the IVF cycle moves on and for each embryo transfer

V Grzegorczyk-Martin, J Roset, P Di Pizio… - Journal of Assisted …, 2022 - Springer
Purpose To dynamically assess the evolution of live birth predictive factors' impact
throughout the in vitro fertilization (IVF) process, for each fresh and subsequent frozen …

[HTML][HTML] A flexible short protocol in women with poor ovarian response over 40 years old

X Zhang, T Feng, J Yang, Y Hao, S Li, Y Zhang… - Journal of Ovarian …, 2021 - Springer
Background Ovarian responsiveness to controlled ovarian stimulation is essential for a
successful clinical outcome in assisted reproductive technology (ART) cycles. We aimed to …

[HTML][HTML] Anti-Müllerian hormone and live birth in unexplained recurrent pregnancy loss

S Bliddal, U Feldt-Rasmussen, JL Forman… - Reproductive …, 2023 - Elsevier
Research question Is anti-Müllerian hormone (AMH) associated with live birth rate (LBR) in
women with unexplained recurrent pregnancy loss (RPL)? Design Cohort study of women …